Searching for more information on your medications
The FDA approval is currently for adults with: A body mass index (BMI) of 30 or greater (obesity), or A BMI of 27 or greater (overweight) with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol The pill is not currently approved for type 1 diabetes (T1D) management, and the OASIS 4 trial excluded people with type 2 diabetes though that research is ongoing
Quality and potency are guaranteed
These beneficial effects were observed in a dose-dependent manner, emphasizing YSTJs ability to modulate inflammatory pathways and promote nerve repair (Zhang Y
The Be Part of Research portal (bepartofresearch.nihr.ac.uk), run by the NIHR, lists studies recruiting in the UK
A comprehensive 2021 review by Seiwerth and colleagues in Frontiers in Pharmacology surveyed BPC-157 across wound healing contexts including skin, cornea, muscle, tendon, and ligament